This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lucknow, IN (2018)
- Uttar Pradesh, IN (2020)
Company Filing History:
Years Active: 2018-2020
Title: Anil Kumar Tripathi: Innovator in Cancer Therapy
Introduction
Anil Kumar Tripathi is a notable inventor based in Uttar Pradesh, India. He has made significant contributions to the field of cancer therapy, particularly in the treatment of drug-resistant forms of leukemia. With a total of 2 patents to his name, his work is recognized for its potential impact on medical science.
Latest Patents
One of his latest patents is titled "Combination of clofazimine and imatinib for effective therapy of drug-resistant myeloid leukemia." This invention relates to a method of treating chronic myeloid leukemia (CML) or drug-resistant CML. It involves administering a therapeutically effective amount of Clofazimine (CFZ) or its derivatives, either alone or in combination with a tyrosine kinase inhibitor (TKI). The invention also includes a kit for the treatment of CML or drug-resistant CML.
Another significant patent is "Aryl naphthyl methanone oxime(s) and process for preparation thereof." This invention pertains to substituted aryl naphthyl methanone oximes and their derivatives, which are used in the treatment of various forms of leukemia, lymphoma, and solid tumors. The invention aims to address the challenges posed by drug-resistant cancer stem cells.
Career Highlights
Anil Kumar Tripathi is associated with the Council of Scientific & Industrial Research, where he continues to advance research in cancer therapies. His work is characterized by a commitment to developing innovative solutions for complex medical challenges.
Collaborations
He has collaborated with notable colleagues such as Sabyasachi Sanyal and Naibedya Chattopadhyay, contributing to a collaborative environment that fosters innovation and research excellence.
Conclusion
Anil Kumar Tripathi's contributions to cancer therapy through his patents highlight his role as a significant inventor in the medical field. His innovative approaches to treating drug-resistant leukemia demonstrate the potential for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile